Nidan Laboratories and Healthcare Limited (NSE:NIDAN)
India
· Delayed Price · Currency is INR 15.50
-1.10 (-6.63%)
Mar 9, 2026, 1:04 PM IST
NSE:NIDAN Revenue
Nidan Laboratories and Healthcare had revenue of 131.21M INR in the half year ending September 30, 2025, with 10.97% growth. This brings the company's revenue in the last twelve months to 271.16M, up 18.48% year-over-year. In the fiscal year ending March 31, 2025, Nidan Laboratories and Healthcare had annual revenue of 245.28M with 1.45% growth.
Revenue (ttm)
271.16M
Revenue Growth
+18.48%
P/S Ratio
0.79
Revenue / Employee
1.66M
Employees
163
Market Cap
215.45M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aatmaj Healthcare | 218.36M |
| Sangani Hospitals | 316.49M |
| Maitreya Medicare | 459.99M |
| Vaidya Sane Ayurved Laboratories | 979.90M |
| Lotus Eye Hospital and Institute | 516.17M |
| Unihealth Hospitals | 789.82M |
| Max India | 1.84B |
| GPT Healthcare | 4.48B |